Search details
1.
Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 study.
Lancet Oncol
; 24(7): 744-756, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37329891
2.
Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and ß-catenin.
Am J Pathol
; 181(3): 1017-33, 2012 Sep.
Article
in English
| MEDLINE | ID: mdl-22800756
3.
Preclinical targeting of the type I insulin-like growth factor receptor in adrenocortical carcinoma.
J Clin Endocrinol Metab
; 94(1): 204-12, 2009 Jan.
Article
in English
| MEDLINE | ID: mdl-18854392
4.
Peroxisome senescence in human fibroblasts.
Mol Biol Cell
; 13(12): 4243-55, 2002 Dec.
Article
in English
| MEDLINE | ID: mdl-12475949
5.
Late Relapses After High-dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Diffuse Large B-cell Lymphoma in the Rituximab Era.
Clin Lymphoma Myeloma Leuk
; 17(3): 145-151, 2017 03.
Article
in English
| MEDLINE | ID: mdl-27998707
6.
In search of adrenocortical stem and progenitor cells.
Endocr Rev
; 30(3): 241-63, 2009 May.
Article
in English
| MEDLINE | ID: mdl-19403887
7.
The molecular genetics of adrenocortical carcinoma.
Rev Endocr Metab Disord
; 8(4): 343-8, 2007 Dec.
Article
in English
| MEDLINE | ID: mdl-17934868
Results
1 -
7
de 7
1
Next >
>>